Ms. Chiniara was most recently Executive Vice President, Chief Legal Officer and Corporate Secretary of Alexion Pharmaceuticals, a leading rare disease biotechnology company, until its acquisition by AstraZeneca in July 2021 for $39 billion. In this role she was responsible for all legal, intellectual property and governance matters, and was the executive sponsor of the Corporate Social Responsibility program.

Prior to joining Alexion, Ms. Chiniara was General Counsel at Alere, Inc., a point-of-care diagnostics company acquired by Abbott Laboratories in 2017, where she spent over a decade managing various legal and governance functions culminating as the SVP and General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary of the board. Earlier in her career, she was responsible for the legal function of the US neurology division at Serono and was a Partner at the law firm Hale and Dorr LLP (now Wilmer Cutler Pickering Hale and Dorr LLP).

Ms. Chiniara holds a JD from Stanford University School of Law and a BA in Russian studies from Bryn Mawr College in Pennsylvania.